Cardio Diagnostics Holdings, Inc. (CDIO) 是一家上市公司 屬於 醫療保健 板塊，經營於 生物科技 產業. 公司總部位於 Chicago, IL, 美国. 現任CEO為 Meeshanthini V. Dogan.
CDIO 擁有 IPO日期為 2022-01-14, 13 名全職員工, 在 NASDAQ Capital Marke, 市值為 $3.72M.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
